At-home health testing using dried blood spots
Dried Blood Spot Testing for At Home Health
This study is testing a new way for adults to collect blood samples at home using dried blood spots to see if it works well and is easier than traditional blood tests.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | Switch Health Solutions Inc. Industry-sponsored |
| Locations | 1 site (Nepean, Ontario) |
| Trial ID | NCT05430139 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on the development and validation of dried blood spot (DBS) testing for adults, allowing for home collection of blood samples that can be sent to accredited laboratories for analysis. DBS testing is less invasive and more cost-effective compared to traditional blood collection methods, making it an attractive option for patients, especially in remote areas. The study aims to address the challenges of sample stability and transportation while ensuring high-quality testing. Participants will be those visiting a laboratory for routine blood collection, providing a unique opportunity to evaluate the feasibility of at-home DBS testing.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who are visiting the laboratory for routine blood tests.
Not a fit: Patients with pre-existing coagulopathies or those unable to provide informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance accessibility to health testing for patients, particularly those in remote areas, by allowing them to collect samples at home.
How similar studies have performed: While there are numerous publications on DBS testing, this specific approach for adult home collection is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Participant \>=18 years old. 2. Visiting Bio-Test Laboratory for routine, physician-ordered venous blood collection. 3. Able to provide informed consent. Exclusion Criteria: 1. Unable or unwilling to provide informed consent. 2. Pre-existing coagulopathies that might put them at risk for bleeding (e.g., hemophilia) 3. Unable to produce an adequate blood sample.
Where this trial is running
Nepean, Ontario
- Bio-Test Laboratory Inc. — Nepean, Ontario, Canada (Recruiting)
Study contacts
- Principal investigator: Christopher McCudden, PhD,FCACB,FACB,NRCC-CC,DABC — Eastern Ontario Regional Laboratory Association.
- Study coordinator: Kyle Tettman
- Email: Kyle@switchhealth.ca
- Phone: 1 (888) 966-6531
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.